Taiwan permanently bans weight loss drug Belviq

The drug permit license for the weight loss drug Belviq has been permanently revoked in Taiwan, the country's Food and Drug Administration (FDA) said Thursday, citing cancer risks.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)